SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Baker who wrote (493)2/19/1999 12:24:00 AM
From: Steve Research  Read Replies (1) of 569
 
Earnings will be out on This Tuesday, The stock is covered by many wall st. firms and has about 50 % of float in short sellers hands. Bottom line, if we see FDA approval on new plant, earnings are in line and demand rermains strong this stock will move 20 points just from short covering, if earnings are better than expectations, look out! the stock could double as it did after last Q's release. i beleive Pru. has a $74 target on the stock and the analyst is VERY conservative.

PS, many Doctor friends of mine are raving about the product, and I beleive the Doctors have a big incentive in selling the injections rather than the pain killer pills that don't even work. Anyone else hear any Dr. reviews of the Synvisc?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext